Profile and prevalence of aspirin resistance in patients with cardiovascular disease (Q28186905)

8

object named as

E J Topol

0 references

author name string

P A Gum

1

0 references

K Kottke-Marchant

2

0 references

E D Poggio

3

0 references

P A Welsh

5

0 references

L Brooks

6

0 references

S K Sapp

American Journal of Cardiology

7

0 references

language of work or name

English

0 references

publication date

1 August 2001

0 references

published in

0 references

volume

88

0 references

page(s)

230-5

0 references

issue

3

0 references

cites work

One hundred years of aspirin.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

Development of aspirin resistance in persons with previous ischemic stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

Platelet aggregation studies in coronary artery disease. Past 4. Effect of aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

Sex difference in antithrombotic effect of aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

PFA-100 system: a new method for assessment of platelet dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

Effects of acetylsalicylic acid in stroke patients evidence of nonresponders in a subpopulation of treated patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

Aspirin response and failure in cerebral infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes11This study was sponsored by COR Therapeutics Inc., South San Francisco, California; and Schering-Plough Research Institute, Kenilworth, New Jersey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

Cyclooxygenases-1 and −2 of Endothelial Cells Utilize Exogenous or Endogenous Arachidonic Acid for Transcellular Production of Thromboxane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

7 January 2021

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

Association of the platelet Pl(A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

PlA2 polymorphism and efficacy of aspirin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of eryt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901631-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(01)01631-9

1 reference

Consolidated OpenCitations Corpus – April 2017

3467607

3467607

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference